Home > PE Ratio > SUDARSHAN PHARMA INDUSTRIES

SUDARSHAN PHARMA INDUSTRIES
PE (Price/Earnings) Ratio

The Current P/E Ratio of SUDARSHAN PHARMA INDUSTRIES is 40.48.

Share Price ₹37.9Jul 02,2026
Market Cap ₹946.1 Cr
Earnings-TTM₹23.4 CrTTM-Consolidated Results
Price/Earnings40.48xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for SUDARSHAN PHARMA INDUSTRIES
Please provide your vote to see the results
SUDARSHAN PHARMA INDUSTRIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of SUDARSHAN PHARMA INDUSTRIES

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of SUDARSHAN PHARMA INDUSTRIES is calculated as :

Current Market Cap [ ₹946.1 Cr] as on Jul 02,2026

(/) Earnings [ ₹23.4 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 40.48x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for SUDARSHAN PHARMA INDUSTRIES , the investors are currently willing to pay 40.48 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SUDARSHAN PHARMA INDUSTRIES !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of SUDARSHAN PHARMA INDUSTRIES over the last five years.

Historical PE (Price/Earnings) ratio chart of SUDARSHAN PHARMA INDUSTRIES


PE Ratio Performance Analysis for SUDARSHAN PHARMA INDUSTRIES

- SUDARSHAN PHARMA INDUSTRIES 's latest p/e ratio is 40.48x.

- SUDARSHAN PHARMA INDUSTRIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 13.34x.

- SUDARSHAN PHARMA INDUSTRIES 's operated at median p/e ratio of 1.56x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, SUDARSHAN PHARMA INDUSTRIES 's p/e ratio peaked in Mar2025 at 46.06x.

- SUDARSHAN PHARMA INDUSTRIES 's p/e ratio hit its five-year low in Mar2022 of 0x.


How does SUDARSHAN PHARMA INDUSTRIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
SUDARSHAN PHARMA INDUSTRIES 23.3740.48946.1
SUN PHARMACEUTICAL INDUSTRIES LTD11,564.5038.83449,048.0
DIVIS LABORATORIES LTD2,568.0068.99177,179.0
TORRENT PHARMACEUTICALS LTD2,138.0073.81157,804.0
CIPLA LTD3,869.7930.40117,642.0
DR REDDYS LABORATORIES LTD4,144.2027.11112,368.0
MANKIND PHARMA LTD1,926.4153.33102,729.0
LUPIN LTD5,355.4720.48109,676.0
ZYDUS LIFESCIENCES LTD5,026.4021.82109,691.0
AUROBINDO PHARMA LTD3,501.4525.6489,761.8
LAURUS LABS LTD889.8592.6082,398.9

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SUDARSHAN PHARMA INDUSTRIES 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 20.48x
Max industry PE 92.60x
Median industry PE 38.83x
Average industry PE 44.86x



You may also like the below Video Courses